• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表达变化是否影响 SARS-CoV-2 的毒力和相关并发症:对膜结合型和可溶性形式的更深入观察。

Do Changes in Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms.

机构信息

Biomedical Research Center, Qatar University, Doha 2713, Qatar.

Department of Chemistry and Earth Sciences, College of Arts and Sciences, Qatar University, Doha 2713, Qatar.

出版信息

Int J Mol Sci. 2021 Jun 23;22(13):6703. doi: 10.3390/ijms22136703.

DOI:10.3390/ijms22136703
PMID:34201415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8269184/
Abstract

The SARS-CoV-2 virus utilizes angiotensin converting enzyme () for cell entry and infection. This enzyme has important functions in the renin-angiotensin aldosterone system to preserve cardiovascular function. In addition to the heart, it is expressed in many tissues including the lung, intestines, brain, and kidney, however, its functions in these organs are mostly unknown. has membrane-bound and soluble forms. Its expression levels are altered in disease states and by a variety of medications. Currently, it is not clear how altered levels influence virulence and relevant complications. In addition, membrane-bound and soluble forms are thought to have different effects. Most work on this topic in the literature is on the SARS-CoV virus that has a high genetic resemblance to SARS-Co-V-2 and also uses enzyme to enter the cell, but with much lower affinity. More recent studies on SARS-CoV-2 are mainly clinical studies aiming at relating the effect of medications that are thought to influence levels, with COVID-19 outcomes for patients under these medications. This review paper aims to summarize what is known about the relationship between levels and SARS-CoV/SARS-CoV-2 virulence under altered expression states.

摘要

SARS-CoV-2 病毒利用血管紧张素转换酶()进入细胞并感染。该酶在肾素-血管紧张素-醛固酮系统中具有重要功能,可维持心血管功能。除心脏外,它还在许多组织中表达,包括肺、肠、脑和肾,但在这些器官中的功能大多未知。有膜结合和可溶性两种形式。在疾病状态和各种药物的作用下,其表达水平会发生改变。目前尚不清楚改变的水平如何影响病毒的毒力和相关并发症。此外,膜结合形式和可溶性形式可能具有不同的作用。该主题的大多数文献研究都是针对与 SARS-CoV-2 具有高度遗传相似性的 SARS-CoV 病毒,该病毒也利用酶进入细胞,但亲和力要低得多。最近关于 SARS-CoV-2 的研究主要是临床研究,旨在将被认为影响水平的药物的作用与接受这些药物治疗的患者的 COVID-19 结果联系起来。本文旨在总结已知的在改变的表达状态下,水平与 SARS-CoV/SARS-CoV-2 毒力之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/c1e705b27207/ijms-22-06703-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/1468f62463f6/ijms-22-06703-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/c73674c8b96f/ijms-22-06703-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/c2302ce7d8fc/ijms-22-06703-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/b6b21e8d9b16/ijms-22-06703-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/c38bca3c33da/ijms-22-06703-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/33cd4bbc3ae2/ijms-22-06703-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/c1e705b27207/ijms-22-06703-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/1468f62463f6/ijms-22-06703-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/c73674c8b96f/ijms-22-06703-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/c2302ce7d8fc/ijms-22-06703-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/b6b21e8d9b16/ijms-22-06703-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/c38bca3c33da/ijms-22-06703-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/33cd4bbc3ae2/ijms-22-06703-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/8269184/c1e705b27207/ijms-22-06703-g007.jpg

相似文献

1
Do Changes in Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms.表达变化是否影响 SARS-CoV-2 的毒力和相关并发症:对膜结合型和可溶性形式的更深入观察。
Int J Mol Sci. 2021 Jun 23;22(13):6703. doi: 10.3390/ijms22136703.
2
Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.停止使用 ACEI 和 ARB 类药物对 COVID-19 患者的潜在有害影响。
Elife. 2020 Apr 6;9:e57278. doi: 10.7554/eLife.57278.
3
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.血管紧张素转换酶 2 和肾素血管紧张素系统抑制剂在 COVID-19 中的应用:最新进展。
High Blood Press Cardiovasc Prev. 2021 Mar;28(2):129-139. doi: 10.1007/s40292-021-00439-9. Epub 2021 Feb 26.
4
Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation.心血管疾病患者 COVID-19 并发症增加:肾素-血管紧张素-醛固酮系统(RAAS)失调的作用。
Chem Biol Interact. 2022 Jan 5;351:109738. doi: 10.1016/j.cbi.2021.109738. Epub 2021 Nov 3.
5
Is highly expressed ACE 2 in pregnant women "a curse" in times of COVID-19 pandemic?在 COVID-19 大流行期间,孕妇中高表达的 ACE2 是“诅咒”吗?
Life Sci. 2021 Jan 1;264:118676. doi: 10.1016/j.lfs.2020.118676. Epub 2020 Oct 28.
6
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2(ACE2)、严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 冠状病毒病(COVID-19)的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.
7
COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial.2019冠状病毒病、高血压与肾素-血管紧张素-醛固酮系统阻滞剂:BRACE-CORONA试验
Cardiovasc Res. 2020 Dec 1;116(14):e198-e199. doi: 10.1093/cvr/cvaa325.
8
The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy: A Concise Treatise.ACE2 受体在 SARS-CoV-2 感染中的必然作用及药物再利用作为 SARS-CoV-2 治疗的合理策略:简明论述。
Curr Mol Med. 2021;21(10):888-913. doi: 10.2174/1573405617666210204212024.
9
Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.SARS-CoV-2 对心血管系统的影响:血管紧张素转换酶 2(ACE2)作为病毒受体和体内平衡调节剂的双重作用——综述。
Int J Mol Sci. 2021 Apr 26;22(9):4526. doi: 10.3390/ijms22094526.
10
The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections.肾素-血管紧张素系统,特别是血管紧张素转换酶 2 作为 SARS-CoV-2 感染的潜在治疗靶点。
Naunyn Schmiedebergs Arch Pharmacol. 2021 Jul;394(7):1589-1593. doi: 10.1007/s00210-021-02108-z. Epub 2021 Jun 21.

引用本文的文献

1
Vitamin D Status in a Large, Ethnically Diverse Patient Population Living in South East London at the Onset of the COVID-19 Pandemic: A Cross-Sectional Study Including a SARS-CoV-2 Positive Patient Subset.新冠疫情爆发初期伦敦东南部一个种族多样化的大型患者群体的维生素D状况:一项横断面研究,包括新冠病毒检测呈阳性的患者子集
Nutrients. 2025 Sep 4;17(17):2861. doi: 10.3390/nu17172861.
2
Role of mitochondria in physiological activities, diseases, and therapy.线粒体在生理活动、疾病及治疗中的作用。
Mol Biomed. 2025 Jun 19;6(1):42. doi: 10.1186/s43556-025-00284-5.
3
Unveiling the Interplay-Vitamin D and ACE-2 Molecular Interactions in Mitigating Complications and Deaths from SARS-CoV-2.

本文引用的文献

1
SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention.严重急性呼吸综合征冠状病毒2型疾病辅助疗法及补充剂在感染预防方面取得突破。
Microorganisms. 2021 Mar 4;9(3):525. doi: 10.3390/microorganisms9030525.
2
A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection.一种新型 ACE2 同种型在人呼吸道上皮细胞中表达,并可响应干扰素和 RNA 呼吸道病毒感染而上调。
Nat Genet. 2021 Feb;53(2):205-214. doi: 10.1038/s41588-020-00759-x. Epub 2021 Jan 11.
3
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives.
揭示维生素D与血管紧张素转换酶2(ACE-2)的分子相互作用在减轻新冠病毒(SARS-CoV-2)并发症和死亡方面的作用
Biology (Basel). 2024 Oct 16;13(10):831. doi: 10.3390/biology13100831.
4
Postural Orthostatic Tachycardia Syndrome Associated with COVID-19: A Narrative Review.与 COVID-19 相关的体位性心动过速综合征:一篇叙述性综述。
Medicina (Kaunas). 2024 Aug 15;60(8):1325. doi: 10.3390/medicina60081325.
5
Serum AXL is a potential molecular marker for predicting COVID-19 progression.血清 AXL 是预测 COVID-19 进展的潜在分子标志物。
Front Immunol. 2024 May 10;15:1394429. doi: 10.3389/fimmu.2024.1394429. eCollection 2024.
6
Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation.人支气管上皮细胞转录组对不同炎症状态患者血清的反应变化。
Lung. 2024 Apr;202(2):157-170. doi: 10.1007/s00408-024-00679-1. Epub 2024 Mar 17.
7
Angiotensin I and II Stimulate Cell Invasion of SARS-CoV-2: Potential Mechanism via Inhibition of ACE2 Arm of RAS.血管紧张素I和II刺激新型冠状病毒的细胞侵袭:通过抑制肾素-血管紧张素系统的血管紧张素转换酶2分支的潜在机制。
Physiol Res. 2024 Mar 11;73(1):27-35. doi: 10.33549/physiolres.935198.
8
Blood ACE2 Protein Level Correlates with COVID-19 Severity.血液 ACE2 蛋白水平与 COVID-19 严重程度相关。
Int J Mol Sci. 2023 Sep 11;24(18):13957. doi: 10.3390/ijms241813957.
9
Infections and Autoimmunity-The Immune System and Vitamin D: A Systematic Review.感染与自身免疫:免疫系统与维生素 D:系统评价。
Nutrients. 2023 Sep 2;15(17):3842. doi: 10.3390/nu15173842.
10
Lack of Evidence for a Role of ACE-2 Polymorphisms as a Bedside Clinical Prognostic Marker of COVID-19.缺乏 ACE-2 多态性作为 COVID-19 床边临床预后标志物的证据。
Viruses. 2023 Jun 27;15(7):1448. doi: 10.3390/v15071448.
SARS-CoV-2 时代的血管紧张素转换酶 2:争议与新观点
Front Mol Biosci. 2020 Sep 30;7:588618. doi: 10.3389/fmolb.2020.588618. eCollection 2020.
4
ACE2: The Major Cell Entry Receptor for SARS-CoV-2.血管紧张素转化酶 2:SARS-CoV-2 的主要细胞进入受体。
Lung. 2020 Dec;198(6):867-877. doi: 10.1007/s00408-020-00408-4. Epub 2020 Nov 10.
5
Environmental Issues and Neurological Manifestations Associated with COVID-19 Pandemic: New Aspects of the Disease?与 COVID-19 大流行相关的环境问题和神经表现:疾病的新方面?
Int J Environ Res Public Health. 2020 Nov 1;17(21):8049. doi: 10.3390/ijerph17218049.
6
SARS-CoV-2 Targets by the pscRNA Profiling of ACE2, TMPRSS2 and Furin Proteases.通过对ACE2、TMPRSS2和弗林蛋白酶进行pscRNA分析确定的新型冠状病毒2型(SARS-CoV-2)靶点
iScience. 2020 Nov 20;23(11):101744. doi: 10.1016/j.isci.2020.101744. Epub 2020 Oct 28.
7
COVID-19 - A vascular disease.COVID-19 - 一种血管疾病。
Trends Cardiovasc Med. 2021 Jan;31(1):1-5. doi: 10.1016/j.tcm.2020.10.005. Epub 2020 Oct 14.
8
The Immune Response and Immunopathology of COVID-19.新型冠状病毒肺炎的免疫反应和免疫病理学
Front Immunol. 2020 Aug 26;11:2037. doi: 10.3389/fimmu.2020.02037. eCollection 2020.
9
ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19.ACE2:其在严重急性呼吸综合征和 COVID-19 中的潜在作用和调控。
J Cell Physiol. 2021 Apr;236(4):2430-2442. doi: 10.1002/jcp.30041. Epub 2020 Sep 9.
10
Advances in research on ACE2 as a receptor for 2019-nCoV.新型冠状病毒受体 ACE2 研究进展。
Cell Mol Life Sci. 2021 Jan;78(2):531-544. doi: 10.1007/s00018-020-03611-x. Epub 2020 Aug 11.